Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    P89 - Targeted Therapy - Clinically Focused - Translational

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • +

      P89.01 - Clinical and Genomic Features of EGFR-KDD/EGFR Rearrangements of Chinese Lung Cancer Patients

      00:00 - 00:00  |  Presenter: Chengzhi Zhou

      • Abstract

      Loading...

    • +

      P89.02 - The Effect of Racial Diversity on the Landscape of Targetable Genomic Alterations in Patients with Lung Adenocarcinomas

      00:00 - 00:00  |  Presenter: Yanyan Lou

      • Abstract

      Loading...

    • +

      P89.03 - Demonstrating VALUE of Liquid Biopsy for Lung Cancer in a Public Healthcare System

      00:00 - 00:00  |  Presenter: Desiree Hao

      • Abstract

      Loading...

    • +

      P89.04 - Real-World First Line Targeted Therapy Duration Following ctDNA Testing in Advanced Non-Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Chuck H. Hensel

      • Abstract

      Loading...

    • +

      P89.05 - Management of Patients with EGFR and ALK-Mutated Advanced Non-Small Cell Lung Cancer Post-TKI Therapy – A Real-World Survival Analysis

      00:00 - 00:00  |  Presenter: Kathleen Claire Kerrigan

      • Abstract

      Loading...

    • +

      P89.06 - Prospective Concordance Study of a Multi-Gene PCR Assay and NGS for the Detection of Targetable Gene Alterations in Lung Cancer

      00:00 - 00:00  |  Presenter: Shingo Matsumoto

      • Abstract

      Loading...

    • +

      P89.07 - A Large-Scale Survey of IDH1/2 Mutation in Chinese Patients With NSCLC  

      00:00 - 00:00  |  Presenter: Meizi Jin

      • Abstract

      Loading...

    • +

      P89.08 - Real-World Impact of Plasma Cell-Free DNA Next-Generation Sequencing to Detect Actionable Genomic Alterations in Advanced NSCLC

      00:00 - 00:00  |  Presenter: Beung-Chul Ahn

      • Abstract

      Loading...

    • +

      P89.09 - The Landscape of Kinase Domain Duplication (KDD) in Chinese Lung Cancer Patients

      00:00 - 00:00  |  Presenter: Pingli Wang

      • Abstract

      Loading...

    • +

      P89.10 - Genomic Alteration Features and Targeted Therapy Opportunities of Primary Thoracic Sarcoma Patients

      00:00 - 00:00  |  Presenter: Lixia Ju

      • Abstract

      Loading...

    • +

      P89.11 - Mutational Profile of Multiple Lung Cancers in Xuanwei by Next-Generation Sequencing

      00:00 - 00:00  |  Presenter: Gang Guo

      • Abstract

      Loading...

    • +

      P89.12 - Real World Outcomes in EGFR-Mutant Relapsed and De Novo Stage IV Non-Small Cell Lung Cancer (NSCLC)

      00:00 - 00:00  |  Presenter: Amanda Jane Williams Gibson

      • Abstract

      Loading...

    • +

      P89.13 - Real-World Experience of NGS-Based Molecular Profiling in ‘Triple-Negative’ (EGFR/ALK/ROS1) Advanced NSCLC: Should we keep Testing Smokers?

      00:00 - 00:00  |  Presenter: Francesca Simionato

      • Abstract

      Loading...

    • +

      P89.14 - Preliminary Study on CTCs and CTECs in Non-Small Cell Lung Cancer Received Chemotherapy Combined with Anti-Angiogenic Therapy

      00:00 - 00:00  |  Presenter: LINA Zhang

      • Abstract

      Loading...

    • +

      P89.15 - Multiple Driver Oncogenes from Plasma of NSCLC Patients

      00:00 - 00:00  |  Presenter: Sita Andarini

      • Abstract

      Loading...

    • +

      P89.18 - Comprehensive Molecular Characterization of Chinese Patients with Oesophageal Cancer Related with Age

      00:00 - 00:00  |  Presenter: Lianke Liu

      • Abstract

      Loading...

  • +

    P90 - Targeted Therapy - Clinically Focused - Misc. Topics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • +

      P90.01 - Clinical Characteristics and Outcome of Patients with Non-Small Cell Lung Cancer Harboring BRAF Mutations  

      00:00 - 00:00  |  Presenter: mina Zhang

      • Abstract

      Loading...

    • +

      P90.02 - BRAF Mutation And Peridiagnosis Thromboembolic Events In Advanced NSCLC Patients

      00:00 - 00:00  |  Presenter: Inmaculada Aparicio Salcedo

      • Abstract

      Loading...

    • +

      P90.03 - A Phase 2 Trial of MRTX849 in Combination with Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

      00:00 - 00:00  |  Presenter: Alex I. Spira

      • Abstract

      Loading...

    • +

      P90.04 - RAS Precision Medicine Trans-Atlantic Partnership: Multi-Centre Pooled Analysis of RAS Pathway Mutations in Advanced NSCLC

      00:00 - 00:00  |  Presenter: Helen Adderley

      • Abstract

      Loading...

  • +

    P92 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Misc. Topics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      P92.01 - Genetic Landscape and Potential Therapy Regimen of Thymic Tumor

      00:00 - 00:00  |  Presenter: Naixin Liang

      • Abstract

      Loading...

  • +

    P94 - Pathology, Molecular Pathology and Diagnostic Biomarkers - Misc. Topics

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P94.01 - Comparison of Driver Mutations in Primary and Metastatic Lung Cancer

      00:00 - 00:00  |  Presenter: Xin Hong

      • Abstract

      Loading...